Berman Nathan Joel 4
4 · Exactus, Inc. · Filed Jul 6, 2021
Insider Transaction Report
Form 4
Exactus, Inc.EXDI
Berman Nathan Joel
CONTROLLER & PRIN ACTNG OFCR
Transactions
- Award
Common Stock
2021-06-30+496,957→ 496,957 total - Award
Stock Options (Right to Buy)
2021-06-30+496,957→ 496,957 totalExercise: $0.10Exp: 2026-06-30→ Common Stock (496,957 underlying)
Footnotes (2)
- [F1]The shares of common stock of the Issuer were acquired in exchange for shares of common stock of Panacea Life Sciences, Inc. ("Panacea"), in connection with the Securities Exchange Agreement dated June 30, 2021 by and among the Issuer, Panacea and the shareholders of Panacea.
- [F2]One-half of the stock options vest upon the effective date of a 1:28 reverse stock split of the Issuer's common stock, and the remainder vest on June 30, 2022, subject to continued employment with the Issuer.